Concorde Asset Management’s Novo Nordisk NVO Stock Holding History

Concorde Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$284K	Hold	4,359	–	–	0.15%	120
2024 Q4	$375K	Hold	4,359	–	–	0.2%	87
2024 Q3	$519K	Sell	4,359 -556	-11%	-$74.2K	0.29%	60
2024 Q2	$702K	Buy	4,915 +356	+8%	+$47.2K	0.43%	35
2024 Q1	$585K	Sell	4,559 -200	-4%	-$23.8K	0.4%	43
2023 Q4	$492K	Buy	4,759 +259	+6%	+$25.6K	0.34%	53
2023 Q3	$409K	Sell	4,500 -88	-2%	-$7.75K	0.37%	58
2023 Q2	$371K	Buy	4,588 +88	+2%	+$7.19K	0.34%	63
2023 Q1	$358K	Hold	4,500	–	–	0.42%	44
2022 Q4	$305K	Sell	4,500 -1,644	-27%	-$96.4K	0.27%	91
2022 Q3	$306K	Buy	6,144 +92	+2%	+$4.93K	0.34%	90
2022 Q2	$337K	Hold	6,052	–	–	0.51%	55
2022 Q1	$336K	Sell	6,052 -22	-0.4%	-$1.13K	0.22%	98
2021 Q4	$340K	Hold	6,074	–	–	0.2%	116
2021 Q3	$292K	Buy	6,074 +52	+0.9%	+$2.51K	0.17%	150
2021 Q2	$252K	Hold	6,022	–	–	0.14%	156
2021 Q1	$203K	Hold	6,022	–	–	0.12%	204
2020 Q4	$211K	Buy	6,022 +22	+0.4%	+$760	0.12%	137
2020 Q3	$208K	Buy	+6,000	New	+$200K	0.12%	164

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Concorde Asset Management's NVO Position: Q1 2025 in Review

Concorde Asset Management held its Novo Nordisk (NVO) position steady in Q1 2025 at 4,359 shares worth $284K. The position accounts for 0.15% of the portfolio, ranked #120.

Concorde Asset Management first reported a position in NVO in Q3 2020 and has held it in 19 quarters since. The position peaked at $702K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

Concorde Asset Management held 4,359 shares of Novo Nordisk worth $284K as of Q1 2025.
Concorde Asset Management left its Novo Nordisk share count unchanged in Q1 2025.
Novo Nordisk made up 0.15% of Concorde Asset Management's portfolio in Q1 2025, its #120 holding.
Concorde Asset Management first reported a position in Novo Nordisk in Q3 2020 and has held it in 19 quarters since.
Concorde Asset Management's Novo Nordisk position peaked at $702K in Q2 2024.
1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Concorde Asset Management's 13F filing for Q1 2025, filed 15 May 2025.